Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 581Neoplasms 486Prostatic Neoplasms 309Lung Neoplasms 240Colorectal Neoplasms 202Motor Activity 131Carcinoma, Non-Small-Cell Lung 117Brain Neoplasms 112Uterine Cervical Neoplasms 111Pancreatic Neoplasms 108Head and Neck Neoplasms 106Carcinoma, Hepatocellular 100Stomach Neoplasms 99Rectal Neoplasms 97Ovarian Neoplasms 86Colonic Neoplasms 86Neoplasm Metastasis 67Multiple Myeloma 65Esophageal Neoplasms 65Urinary Bladder Neoplasms 61Hematologic Neoplasms 61Glioblastoma 60Sarcoma 58Precursor Cell Lymphoblastic Leukemia-Lymphoma 58Melanoma 58Endometrial Neoplasms 55Glioma 53Lymphoma 50Gastrointestinal Neoplasms 49Leukemia, Myeloid, Acute 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Recruiting × Safety Issues × Clear all
NCT06509490 2024-07-19

NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase NA Recruiting
9 enrolled

Safety Issues

Data powered by HemOnc (CC BY 4.0) Colophon âš¡